FH and familial hyperaldosteronism: Polymorphisms in this FH NFκΒ promoter binding site have been identified in humans that link higher expression of FH with reduced severity of disease [51], suggesting this element has functional importance and thus the lack of NFκΒ-driven FH responses in mice may inherently predispose mice to increased disease severity.